249491419 | PUO | 63001608 | | 6396323 | 2/15/2005 12:00:00 AM | djd L knee , htn , bee sting allergy , obesity , hepatitis C virus | | DIS | Admission Date: 6/15/2005 Report Status: 

Discharge Date: 3/28/2005 ****** FINAL DISCHARGE ORDERS ****** AGRESTE , KENNA 874-65-31-1 Roche , AL Service: ORT DISCHARGE PATIENT ON: 2/21/05 AT 01:00 PM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: FANIEL , GAYLENE , M.D. DISPOSITION: Rehabilitation DISCHARGE MEDICATIONS: TYLENOL ( ACETAMINOPHEN ) 650 MG PO Q4H PRN Other:fever greater than 101 Instructions: Do not exceed 4000mg in 24 hours. 
ATENOLOL 100 MG PO QD CALCIUM CARBONATE ( 500 MG ELEMENTAL CA++ ) 500 MG PO QD COLACE ( DOCUSATE SODIUM ) 100 MG PO BID FAMOTIDINE 20 MG PO BID Override Notice: Override added on 5/25/05 by ARTERS , JEROLD E. on order for BUPIVACAINE 0.5% ED 80 ML OTHER ( ref # 19455620 ) POTENTIALLY SERIOUS INTERACTION: FAMOTIDINE &amp; BUPIVACAINE HCL Reason for override: monitor INR Previous override information: Override added on 5/26/05 by SPLETZER , ZENAIDA KAREY , M.D. on order for BUPIVACAINE 0.5% ED 80 ML OTHER ( ref # 06414152 ) POTENTIALLY SERIOUS INTERACTION: FAMOTIDINE &amp; BUPIVACAINE HCL Reason for override: monitor INR FERROUS SULFATE 325 MG PO TID Food/Drug Interaction Instruction Avoid milk and antacid FOLATE ( FOLIC ACID ) 1 MG PO QD MVI ( MULTIVITAMINS ) 1 TAB PO QD OXYCODONE 10-20 MG PO Q3H PRN Pain METAMUCIL SUGAR FREE ( PSYLLIUM ( METAMUCIL ) SU... ) 1 PACKET PO QD PRN Constipation Instructions: may be given with the patients choice of beverage COUMADIN ( WARFARIN SODIUM ) 7.5 MG PO QPM Starting ROUTINE , 20:00 ( Standard Admin Time ) Instructions: Dose for 10/11/05 .  
Please check INR daily while in rehab and then QMonday/Thursday. 
Goal INR=1.5-2.5 , duration is 3 weeks. 
INR at discharge was 1.1 after 6mg. 
Have results sent to MMC primary care provider. 
Food/Drug Interaction Instruction No high Vitamin-K containing foods Reason: Override added on 5/25/05 by ARTERS , JEROLD E. on order for BUPIVACAINE 0.5% ED 80 ML OTHER ( ref # 19455620 ) SERIOUS INTERACTION: WARFARIN &amp; BUPIVACAINE HCL SERIOUS INTERACTION: WARFARIN &amp; BUPIVACAINE HCL Reason for override: monitor INR Previous override information: Override added on 5/26/05 by SPLETZER , ZENAIDA KAREY , M.D. on order for BUPIVACAINE 0.5% ED 80 ML OTHER ( ref # 06414152 ) SERIOUS INTERACTION: WARFARIN &amp; BUPIVACAINE HCL SERIOUS INTERACTION: WARFARIN &amp; BUPIVACAINE HCL Reason for override: monitor INR OXYCONTIN ( OXYCODONE CONTROLLED RELEASE ) 10 MG PO Q12H CHOLECALCIFEROL 400 UNITS PO QD DIET: No Restrictions ACTIVITY: Full weight-bearing: please increase ROM , leg strength , and work on ambulation FOLLOW UP APPOINTMENT( S ): Please follow-up with Dr. Rademan in 4-5 weeks , primary care physician , Arrange INR to be drawn on 6/1/05 with f/u INR's to be drawn every 1daywhileinrehab , thenqMOnday/Thursday days. 
INR's will be followed by Karina Floyd , MD at ( 373 ) 568-4909 MMC primary care provider ALLERGY: NKA ADMIT DIAGNOSIS: djd L knee , htn , bee sting allergy , obesity , hepatitis C virus PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) djd L knee , htn , bee sting allergy , obesity , hepatitis C virus OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay same OPERATIONS AND PROCEDURES: 8/21/05 FANIEL , GAYLENE , M.D. L. TOTAL KNEE REPALACEMENT OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) none BRIEF RESUME OF HOSPITAL COURSE: 54 year-old female patient with PMH htn , obesity , bee sting allergy , and hepatitis C , underwent left total knee arthroplasty on 11/10/05 .  
The patient tolerated the procedure well was managed per the pathway and had no major events. 
Neurologic: Pain was initially managed with an epidural followed by oral pain mediciation. 
Respiratory: The patient's oxygen saturations gradually improved and at the time of discharge they were weaned to room air. 
Cardiovascular: The patient was maintained on his/her home blood pressure medications and their blood pressure remained well controlled throughtout their hospitalization. 
Hematologic: The patient's hematocrit remained stable throughout the hospitalization and was 31.4 on POD#2. 
INR increased slowly with coumadin and at discharge was xx. Fluids/Electrolytes/Nutrition: Their potassium and magnesium were checked frequently during the admission and repleted as needed. 
They were tolerating a regular diet at discharge. 
Orthopedic: The patient worked with physical therapy and had a achieved good ROM and was able to ambulate with assist at discharge. 
Their wound appeared clean , dry , and intact. 
ADDITIONAL COMMENTS: Dry sterile dressing to wound. 
May leave open to air when dry. May shower when wound dry x48 hrs. 
Staple removal/steri-strip application ( on POD 14 , March , 2005 ). 
Coumadin x 3 wks. 
Day after discharge and biweekly PT/INR blood draws ( q M/R ). 
Follow up with doctor as scheduled DISCHARGE CONDITION: Stable TO DO/PLAN: 1 ) Please arrange for blood draws ( PT/INR ) on day after discharge and Q M/R thereafter. 
Pleae check daily while in rehab. 
Have reports phoned in to A Triaded Health PCP , Karina Floyd , MD at ( 272 ) 369-4757. 2 ) Follow up with doctor as scheduled. 
Continue working on knee ROM , strengthening , and ambulation. 
3 ) Please check Magnesium level 6/1/05 AM and phone results to PCP for further instructions; pt with hx of hypomagnesemia , Mg=1.7 during hospitalization and s/p repletion with 2000mg Magnesium Gluconate PO x 1 on 10/11/05 .  
No dictated summary ENTERED BY: DEMOREST , MEGHAN O , M.D. ( PI820 ) 2/21/05 @ 11:00 AM ****** END OF DISCHARGE ORDERS ******